IP Library Patent Application 18509884
Patent Application
App. No. 18/509,884

Analysis of Chromatin Using a Nicking Enzyme

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/509,884
Abstract

Provided herein, among other things, are various compositions and methods for analyzing chromatin. In some embodiments, the composition may comprise a mixture of a nicking enzyme, four dNTPs, at least one labeled dNTP and, optionally, a polymerase. In some embodiments, this method may comprise: obtaining a sample comprising chromatin, reacting the sample with the composition to selectively label the open chromatin in the sample, and analyzing the labeled sample.

Claims (23)

1 - 42 . (canceled)

43 . A method for detecting open chromatin in fixed or unfixed cell nuclei, comprising:

(a) reacting a sample containing fixed or unfixed cell nuclei, wherein the cell nuclei comprise chromatin, with:

(i) a reaction mixture comprising a nicking enzyme, and

(ii) a ligase and adaptors; and

(b) enriching for, optionally amplifying, and then sequencing DNA fragments that comprise the adaptors.

44 . The method of claim 43 , wherein the nicking enzyme is methylation-dependent, methylation-sensitive, or methylation-insensitive.

45 . The method of claim 43 , wherein the nicking enzyme is Nt.CviPII.

46 . The method of claim 43 , wherein the reaction mixture further comprises a polymerase, four dNTPs, and a labeled dNTP.

47 . The method of claim 46 wherein, after reaction step (a), the method comprises reverse cross-linking and isolating labelled genomic DNA, and then fragmenting the isolated labelled genomic DNA, prior to reaction step (b); optionally wherein the reverse cross-linking is done using heat or chemical treatment; optionally wherein the DNA is fragmented to a median size in the range of 100bp-lkg.

48 . The method of claim 47 , further comprising performing end-repair and/or dA tailing, and then adaptor ligation.

49 . The method of claim 43 , wherein the adaptors comprise an affinity tag.

50 . The method of claim 46 , wherein the labelled dNTP is affinity labeled.

51 . The method of claim 50 , wherein step (b) comprises capturing affinity-labelled DNA fragments using a capture moiety; optionally wherein the capture moiety is linked to a solid phase.

52 . The method of claim 51 , wherein the affinity label is biotin, and the capture moiety comprises streptavidin.

53 . The method of claim 43 , wherein step (b) comprises amplifying; optionally using barcoded primers and/or wherein the adaptors comprise a barcode sequence.

54 . The method of claim 43 , further comprising mapping a sequence read obtained from the sequencing of step (b) onto a genomic sequence.

55 . The method of claim 43 , further comprising: analyzing a first population of cells using the method claim 43 to produce a first data set and optionally a first epigenetic map; and

analyzing a second population of cells using the same method to produce a second data set and optionally a second epigenetic map; and comparing the first data set or epigenetic map to the second data set or epigenetic map.

56 . The method of claim 55 , wherein the first population of cells and the second population of cells are from the same individual at different times.

57 . The method of claim 55 , wherein the first population of cells and the second population of cells are different populations of cells from different tissues or from different individuals.

58 . The method of claim 43 , wherein the cell nuclei are obtained from a cell culture.

59 . The method of claim 43 , wherein the cell nuclei are obtained from a sample from an individual, optionally selected from a bodily fluid and a biopsy.

Assignments (2)
SECURITY INTEREST Recorded May 29, 2026
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 074795/0566 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2023
From: PONNALURI, CHAITHANYA; CHIN, HANG-GYEONG; ESTEVE, PIERRE OLIVER; PRADHAN, SRIHARSA
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 065584/0070 →